Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized phase III study of neoadjuvant chemotherapy followed by surgery vs. concomitant chemoradiotherapy in cervical cancer
2008-003396-52Phase 3Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of cisplatin in Cervical Cancer (CC) (2 arms), sponsored by European Organisation for Research and Treatment of Cancer. Primary endpoint: overall survival. Started Sep 2009; status: completed.
02
Drugs
cisplatin
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on 2008-003396-52.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003396-52.